Dana-Farber Cancer Institute

Dana-Farber Cancer Institute is a world-renowned cancer treatment and research center located in Boston, Massachusetts. Founded in 1947 by pathologist Sidney Farber, it is a principal teaching affiliate of Harvard Medical School and a federally designated Comprehensive Cancer Center. The institute is internationally recognized for its pioneering work in childhood cancers, adult oncology, and groundbreaking basic and translational research.

History

The institute was originally established in 1947 as the Children's Cancer Research Foundation, driven by the work of Sidney Farber, who is often called the father of modern chemotherapy. Farber achieved the first temporary remissions in childhood leukemia using the antifolate drug aminopterin, marking a pivotal moment in oncology. In 1969, the foundation was renamed the Sidney Farber Cancer Center in his honor. A significant gift from the Charles A. Dana Foundation in 1983 led to the current name, Dana-Farber Cancer Institute. Its long-standing clinical partnership with Brigham and Women's Hospital was formalized in the 1990s to create Dana-Farber/Brigham and Women's Cancer Center, and it is a founding member of the Dana-Farber/Harvard Cancer Center, a National Cancer Institute-designated consortium.

Research and discoveries

Research spans basic science, translational studies, and clinical trials, with historic contributions including the development of the first successful chemotherapy regimens for pediatric leukemia. Scientists here played key roles in the development of Gleevec for chronic myeloid leukemia and Herceptin for HER2-positive breast cancer. The institute is a leader in immunotherapy, including CAR T-cell therapy and immune checkpoint inhibitors. Ongoing research focuses on cancer genomics, precision medicine, tumor immunology, and early detection. Its researchers have been involved in major initiatives like The Cancer Genome Atlas and maintain extensive collaborations with the Broad Institute and other entities within Harvard University.

Patient care and clinical services

Patient care is delivered primarily through Dana-Farber/Brigham and Women's Cancer Center for adults and Dana-Farber/Boston Children's Cancer and Blood Disorders Center for pediatric patients, in partnership with Boston Children's Hospital. The institute operates numerous specialized treatment centers for diseases such as breast cancer, gynecologic cancers, melanoma, and hematologic malignancies. It offers access to a vast portfolio of clinical trials, supportive care services like the Leonard P. Zakim Center for Integrative Therapies and Healthy Living, and satellite locations throughout New England. Its Jimmy Fund, established in 1948, is a famous philanthropy supporting both patient care and research.

Affiliations and partnerships

As a founding member of the Dana-Farber/Harvard Cancer Center, it collaborates closely with Harvard Medical School, Brigham and Women's Hospital, Boston Children's Hospital, Beth Israel Deaconess Medical Center, and Massachusetts General Hospital. These affiliations create an integrated network for research and patient care. The institute is also a member of the National Comprehensive Cancer Network and partners with industry leaders in biotechnology and pharmaceuticals for drug development. Its global outreach includes research and training initiatives with institutions worldwide.

Leadership and organization

The institute is led by President and CEO Laurie H. Glimcher, a noted immunologist. It is governed by a Board of Trustees and operates under the umbrella of Dana-Farber Cancer Institute, Inc., which also oversees the Jimmy Fund. The organization is structured into numerous research departments and disease-centered divisions, all integrated with the teaching mission of Harvard Medical School. Notable past leaders include David G. Nathan and Edward J. Benz Jr., who oversaw periods of significant expansion.

Category:Cancer research organizations Category:Harvard Medical School Category:Organizations based in Boston Category:Medical and health organizations based in Massachusetts